Anisodamine Hydrobromide

氢溴酸山莨菪碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnisodamine Hydrobromide
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsGastrospasmVertigoShock, Septic
Global Approved IndicationsGastrospasmVertigoShock, Septic
Approved Indications in ChinaGastrospasmVertigoShock, Septic
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co LtdChengdu First Pharmaceutical Co LtdTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrospasmVertigoShock, Septic
Inactive IndicationsN/A

Other Information

ATC CodeV
Related LinksWikipediaDrugBankKEGG